## MKC: McCormick & Company, Incorporat - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 2.7% below STRENGTH zone (3.0-6.0%); PEG 2.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($65.96)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Addenda Capital Inc. Purchases Shares of 46,996 McCormick & Company, Incorporated $MKC**
- Source: MarketBeat | 20251219T080928 | Neutral | Relevance: 100%
- Addenda Capital Inc. acquired a new stake of 46,996 shares in McCormick & Company, Incorporated, valued at approximately $3.15 million during the third quarter. Institutional investors now own about 79.74% of the stock. McCormick has increased its quarterly dividend to $0.48 per share, while insiders have sold a total of 146,158 shares worth approximately $9.56 million over the past three months.

**2. Thurston Springer Miller Herd & Titak Inc. Sells 20,930 Shares of McCormick & Company, Incorporated $MKC**
- Source: MarketBeat | 20251217T150933 | Neutral | Relevance: 100%
- Thurston Springer Miller Herd & Titak Inc. significantly reduced its holdings in McCormick & Company, Inc. (NYSE:MKC) by selling 20,930 shares, representing a 90.8% decrease in Q3. This move leaves the firm with 2,115 shares valued at approximately $141,000. McCormick has also seen recent insider selling from its CEO and other major shareholders, totaling over $9.5 million in the past three months, although insiders still own 23.8% of the company.

**3. McCormick & Company, Incorporated $MKC Shares Purchased by Corient Private Wealth LLC**
- Source: MarketBeat | 20251217T100928 | Somewhat-Bullish | Relevance: 100%
- Corient Private Wealth LLC increased its stake in McCormick & Company, Incorporated (NYSE:MKC) by 6.0% during the second quarter, bringing its total holdings to 496,100 shares valued at $37.61 million. Other institutional investors also adjusted their positions, and analysts have issued various ratings for MKC, with a consensus "Hold" rating and an average price target of $78.00. The company recently reported earnings that topped consensus estimates and announced an increased quarterly dividend.

**4. Natural And Organic Flavors Market is Booming with Strong Growth**
- Source: openPR.com | 20251219T095525 | Somewhat-Bullish | Relevance: 64%
- Coherent Market Insights projects strong growth for the Natural And Organic Flavors Market from 2025 to 2032 due to rising industry demand, expanding applications, and technological advancements. The report provides a comprehensive overview of market size, revenue trends, key growth factors, and a detailed competitive analysis, offering actionable insights for strategic decision-making. Leading companies in the market include Givaudan S.A., International Flavors & Fragrances Inc., Firmenich SA, and Symrise AG.

**5. What To Expect From Lamb Weston's (LW) Q4 Earnings**
- Source: Finviz | 20251218T060816 | Neutral | Relevance: 60%
- Lamb Weston (NYSE:LW) is set to announce its Q4 earnings this Friday before market open. Analysts expect revenue to be flat year-on-year at $1.59 billion and adjusted earnings at $0.65 per share, with estimates largely reconfirmed. The company has a record of beating revenue expectations but has missed overall Wall Street estimates three times in the last two years.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 19 ($0.04M) |
| Sells | 3 ($3.67M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.8% (-0.2%)
- Blackrock Inc.: 7.8% (+1.2%)
- State Farm Mutual Au: 6.5% (0.0%)
- State Street Corpora: 6.1% (+5.1%)
- Geode Capital Manage: 2.5% (+1.1%)

### Key Risks

1. Insider selling cluster: $3.7M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.87 signals overvaluation risk, limited margin of safety. Forward P/E 21.3x stretched relative to 6% growth. Insider selling cluster ($3.7M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $18.4B |
| Beta | 0.62 |
| 52W Range | $62.64 - $86.24 |
| Short Interest | 0.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.87 |
| Forward P/E | 21.3 |
| Current P/E | 22.7 |
| YoY Growth | 6.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 7.3% to 2.7% (-4.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.3pp (needs >3.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.96x), long-term trend not supportive. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.69% (CS: 89) | Neutral |
| RSI_14 | 62.8 | Neutral |
| MACD Histogram | 0.45 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 0.960x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $68.58
- **Stop Loss:** $65.96 (3.8% risk)
- **Target:** $71.20 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 458
- **Position Value:** $31,409.64
- **Portfolio %:** 31.41%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-29 (Est: $0.87)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.82 | $0.85 | +4.2% |
| 2025Q2 | $0.65 | $0.69 | +5.7% |
| 2025Q1 | $0.64 | $0.60 | -6.9% |
| 2024Q4 | $0.77 | $0.80 | +4.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*